The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro 12.5mg — Dose Information for UK Adults
Mounjaro 12.5mg is one of the highest escalation doses of tirzepatide available in the UK as a prescription-only weight management injection. This dose is typically reached after several weeks of gradual dose increases, starting from 2.5mg and moving through 5mg, 7.5mg, 10mg, and 15mg stages. The 12.5mg dose sits between the 10mg and maximum 15mg levels. This guide explains how the 12.5mg dose works, what to expect, and whether it may be suitable for you following a clinical assessment with a GP or licensed prescriber.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How the Mounjaro 12.5mg Dose Works
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, meaning it activates two natural hormone pathways in your body. At the 12.5mg dose, this mechanism may help reduce appetite, decrease food cravings, and support feeling fuller after eating smaller meals. The medication also slows gastric emptying—how quickly food leaves your stomach—though this effect typically reduces over time. You inject 12.5mg once weekly using a pre-filled KwikPen device, rotating your injection site each week between your stomach, upper thigh, or upper arm. The 12.5mg dose is usually reached after a minimum of 4 weeks on each lower dose, as your body adjusts to the medication. Clinical trials showed that higher doses of tirzepatide, including in this range, resulted in average weight loss of around 20% of body weight alongside a reduced-calorie diet and increased physical activity. However, individual results vary significantly—some people may reach their weight loss goals at lower doses, while others may escalate to the maximum 15mg dose for optimal results.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro 12.5mg Side Effects and Safety
At the 12.5mg dose, side effects are typically similar to lower doses but may be more pronounced as your body receives a higher amount of tirzepatide. The most common side effects include nausea, diarrhoea, vomiting, constipation, and stomach pain—these are usually mild to moderate and tend to improve over time as your body adjusts. Less common side effects include indigestion, fatigue, dizziness, injection site reactions, and hair loss. If you experience severe, persistent stomach pain that spreads to your back, seek urgent medical attention as this may indicate pancreatitis. Before starting the 12.5mg dose, inform your prescriber of all medications you take, as tirzeaptide may affect how some oral medications are absorbed. Women using oral contraceptives should use a barrier method or switch contraception during dose escalations. Your prescriber will monitor your health regularly while you're on this dose.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
How long does it take to reach the Mounjaro 12.5mg dose?
You start at 2.5mg and increase by 2.5mg or 5mg increments, spending a minimum of 4 weeks on each dose. Reaching 12.5mg typically takes around 16–20 weeks from your starting dose, though timescales vary based on how your body responds and tolerates each escalation.
Will I lose more weight at Mounjaro 12.5mg than at lower doses?
Clinical trials suggest that higher tirzepatide doses generally support greater average weight loss. However, individual results vary considerably—some people achieve their weight loss goals at 5mg or 10mg, while others benefit from escalating further. Your prescriber will assess your progress at each dose.
Can I get Mounjaro 12.5mg on the NHS in the UK?
Mounjaro is available through NHS specialist weight management services (tier 3/4), though regional availability and waiting lists vary significantly. You can also access it privately through a UK-licensed prescriber following an online clinical assessment, though this involves a private cost.
What's the difference between Mounjaro 12.5mg and Wegovy for weight loss?
Mounjaro (tirzepatide) is a dual GIP and GLP-1 agonist, while Wegovy (semaglutide) activates only the GLP-1 pathway. Clinical trials showed tirzepatide resulted in approximately 20% average weight loss versus 15% with semaglutide, though individual responses differ and both require prescription and clinical assessment.
Can I skip doses or stop Mounjaro 12.5mg whenever I want?
You should never skip doses or stop without consulting your prescriber. Stopping suddenly may cause weight regain. Your prescriber can advise you on safe discontinuation if you decide to stop treatment. Use our free GLP-1 weight loss calculator to understand potential outcomes and track your progress with our weight loss progress tracker.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.